Posted: July 26, 2013 at 10:42 pm
Matt Wood - High School Stem Cell Research Interns Summer 2013
Matt Wood is a University City High School student who is doing a stem cell research internship this summer in the laboratory of Jim Paulson at the Scripps R...
By: California Institute for Regenerative Medicine
Read more here:
Matt Wood - High School Stem Cell Research Interns Summer 2013 - Video
Posted: July 26, 2013 at 10:42 pm
Caroline Desler - High School Stem Cell Research Intern - Summer 2013
In this video, I introduce myself and my incredible mentor Dr. Ana Aguilar, whom I will be working most closely with throughout this research experience. We ...
By: California Institute for Regenerative Medicine
Read this article:
Caroline Desler - High School Stem Cell Research Intern - Summer 2013 - Video
Posted: July 26, 2013 at 10:42 pm
Caroline Desler - High School Stem Cell Research Intern - Summer 2013, Video Project 2
In this video, I present an overview of the Bradford protein quantification procedure in the lab. Before conducting any kind of protein analysis, i.e. wester...
By: California Institute for Regenerative Medicine
Go here to see the original:
Caroline Desler - High School Stem Cell Research Intern - Summer 2013, Video Project 2 - Video
Posted: July 26, 2013 at 10:42 pm
Ray, Erik, Dustin, Matthew - High School Stem Cell Research Interns - Summer 2013
Ray Solis is a High Tech High North County student, Erik Owen is a Westview High School student, Dustin Nguyen is a Crawford High School student and Matthew ...
By: California Institute for Regenerative Medicine
See the article here:
Ray, Erik, Dustin,
Posted: July 26, 2013 at 10:42 pm
Genevieve, Heather, Sara, Ann - High School Stem Cell Research Interns - Summer 2013
Genevieve DeKorver is a High Tech High School student, Sara D #39;Souza is a Canyon Crest Academy student, Ann Liu is Westview High School student and Heather Ma...
By: California Institute for Regenerative Medicine
See original here:
Genevieve, Heather, Sara,
Posted: July 26, 2013 at 10:42 pm
Fyezah Nazir - High School Stem Cell Research Intern - Summer 2013
Fyezah Nazir is a Mira Mesa High School student who is doing a stem cell research internship this summer in the laboratory of Brunie Felding-Habermann at The...
By: California Institute for Regenerative Medicine
View post:
Fyezah Nazir - High School Stem Cell Research Intern - Summer 2013 - Video
Posted: July 26, 2013 at 10:42 pm
Christina Bui - High School Stem Cell Research Intern Summer 2013 - Video Project 2
Christina Bui is a Piedmont Hills High School student who is doing a stem cell research internship this summer in the laboratory of Theo Palmer at Stanford U...
By: California Institute for Regenerative Medicine
See more here:
Christina Bui - High School Stem Cell Research Intern Summer 2013 - Video Project 2 - Video
Posted: July 26, 2013 at 4:45 pm
SCOTTSDALE, Ariz. -
One in three people in the U.S. suffers with chronic pain. It affects more Americans than diabetes, heart disease and cancer combined. Non-invasive treatments in the past have been limited, but now stem cells could hold the key to the future of pain management.
Bobby Sydnor and his band have something to sing about. Sydnor may have found the answer to his debilitating pain from a motorcycle accident that nearly crushed his spine 40 years ago, leaving him with three degenerative discs.
"Its just excruciating. I remember sometimes crawling to the bathroom," Sydnor said.
Now, thanks to a cutting edge therapy, the bonsai enthusiast is finally getting some relief without surgery.
"It really has the potential to change the disease state, instead of just treating the symptoms," said Dr. Tory L. McJunkin, principal investigator at Arizona Pain Specialists.
McJunkin is involved in a multi-center clinical trial thats using stem cells to regenerate discs in the spine.
"They have the ability to change and to regrow that tissue until its a normal tissue," McJunkin said.
Preclinical studies on sheep showed their discs were regenerated
"The treated disc looks exactly the same, you cant tell a difference at all and the untreated disc is very degenerative, very black, McJunkin said.
Read the original post:
Health Beat: Stem cells to the rescue: Oh, my back!
Posted: July 26, 2013 at 4:42 pm
FAQ4 A Scientific Basis for Stem Cell Therapy
http://youtu.be/uf_toA9Nzuo With all the hype online and in the media today, it is easy to believe that Stem Cell therapy is ALSO #39;hype #39;, but it actually eme...
By: Kerry Dean
View original post here:
FAQ4 A Scientific Basis for Stem Cell Therapy - Video
Posted: July 26, 2013 at 4:42 pm
ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. announced today the release of LifeMap Discovery version 1.2 (discovery.lifemapsc.com). LifeMap Discovery is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining capabilities and bioinformatics applications. As such, it is a unique and powerful tool for research and discovery in multiple disciplines, including stem cell biology, developmental biology and disease mechanisms and etiology.
LifeMap Discovery version 1.2 provides enhanced features related to stem cell therapeutic development
LifeMap Discovery is a key component in LifeMaps integrated database suite, a discovery platform for biomedical and stem cell research, which also includes GeneCards, the leading human gene database, and MalaCards, the human disease database.
LifeMap Discovery version 1.2 new features and information include the following:
LifeMap Discovery version 1.2 provides enhanced features related to stem cell therapeutic development, said Ronit Shtrichman, Ph.D., MBA, Vice President of Biology at LifeMap Sciences. This version includes substantially upgraded information about stem cells with potential therapeutic applications and stem cell differentiation protocols. It also enables researchers to identify genes specifically expressed during embryonic development and stem cells differentiation, providing the means to generate desired cell types for therapeutic applications.
The extensive coverage of the stem cell therapy pipeline and high throughput gene expression data are significant steps forward in developing our premium model, and are of significant interest to companies developing cell-based therapies. Coupled with the commercial offering of recombinant proteins and PureStem progenitors, it is an important milestone for commercialization of the LifeMap Discovery platform, stated Yaron Guan-Golan, Head of Marketing at LifeMap Sciences.
About LifeMap Sciences, Inc.
LifeMap Sciences (www.lifemapsc.com) core technology and business is based on the LifeMap Integrated Biomedical Knowledgebase, the discovery platform for biomedical and stem cell research. This web-based platform includes GeneCards, the leading human gene compendium; LifeMap Discovery, the embryonic development, stem cell research and regenerative medicine compendium; and MalaCards, the human disease compendium. According to Google Analytics, the sites have generated more than 2,000,000 unique visitors with more than 13,000,000 page views, from more than 3,000 universities, institutions and biomedical companies in the past 12 months.
Via LifeMap BioReagents, LifeMap offers leading edge reagents to researchers in academia, research hospitals, and biotech and pharma companies. LifeMap is BioTimes principal marketing subsidiary for research products, including PureStem human progenitor cells, PureStem packages, clinical and research grade human embryonic stem cell (hES) lines, culture media, and cell differentiation kits. The eCommerce portal also offers select recombinant proteins, including growth factors, signaling molecules, differentiation factors, cytokines and chemokines that complement BioTimeresearch product lines.
In therapeutic discovery collaboration with BioTime, LifeMaps scientists utilize the Integrated Biomedical Knowledgebase to aid in the development of BioTimes proprietary library of more than 200 PureStem human progenitor cell types into products for the treatment of human diseases, especially degenerative diseases that might be treatable with cell replacement therapies. A bioinformatics platform developed by LifeMap is used to select the PureStem cells that are most likely to be useful in developing cell-based regenerative medicine therapies for a wide range of diseases.
